Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 11/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.52 |
| ▸ | ATM | Q13315 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | ATR | Q13535 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.47 |
| ▸ | NPC1 | O15118 | 9/20 | 0.47 |
| ▸ | HPGD | P15428 | 7/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 6/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 3/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12721926 | 1.00 | RAB9A (0.52) | RAB9AALDH1A1KDM4EHSD17B10ATM | |
| SCHEMBL10315097 | 0.91 | ATR (0.47) | RAB9AALDH1A1KDM4EHSD17B10ATM | |
| SCHEMBL10315354 | 0.91 | ATR (0.47) | RAB9AALDH1A1KDM4EHSD17B10ATM | |
| SCHEMBL12721860 | 0.88 | ATR (0.53) | RAB9AALDH1A1KDM4EHSD17B10ATM | |
| SCHEMBL12721796 | 0.88 | ALDH1A1 (0.56) | RAB9AALDH1A1KDM4EHSD17B10ATM | |
| SCHEMBL12721924 | 0.86 | RAB9A (0.51) | RAB9AALDH1A1KDM4EHSD17B10ATR | |
| SCHEMBL12722086 | 0.86 | RAB9A (0.51) | RAB9AALDH1A1KDM4EHSD17B10ATR | |
| SCHEMBL12721695 | 0.85 | ATR (0.53) | RAB9AALDH1A1KDM4EHSD17B10ATM | |
| SCHEMBL12721961 | 0.85 | ATR (0.53) | RAB9AALDH1A1KDM4EHSD17B10ATM | |
| SCHEMBL10125953 | 0.85 | ALDH1A1 (0.47) | RAB9AALDH1A1KDM4EHSD17B10ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7927720-B2 | Quinoxaline derivative and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-04-19 | — | — | US | disclosed |
| US-7927720-B2 | Quinoxaline derivative and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-04-19 | — | — | US | disclosed |
| US-20090140641-A1 | Quinoxaline Derivative and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-06-04 | — | — | US | disclosed |
| US-20090140641-A1 | Quinoxaline Derivative and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090140641-A1 | Quinoxaline Derivative and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | PDXK, PPOX, NQO1 | RAB9A 2280/4885ALDH1A1 764/4885KDM4E 1452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.